Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

Correction:

Here is my reasoning:

The bids are dropping and the asks outweigh the BIDS. Waiting for Q3 results without any interim (substantial!!!) news will also drive the stock down. Please note I don't count paid hype as anything close to substantial. I also believe there will be more warrants exercised before the end of October which will drive the stock lower.

The public and MM/Traders already know or believe the revs will be around $5M and that has been discounted. Now if the Revs were going to closer to $6M or $7M, that is a different story. However, without interim news, the stock will continue to drop.

The next resistance is at 0.27 (broken the 0.30 resistance). If 0.27 doesn't hold the next resistance level will be 0.19-0.20 (JMO). I will then buy the shares. I don't see this stock going below 0.19 range.

Also, I don't believe there will be any Fluticare FDA news this year.